Literature DB >> 25320592

Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C.

Shehab M Abd El-Kader1, Osama H Al-Jiffri2, Fadwa M Al-Shreef2.   

Abstract

BACKGROUND: Chronic hepatitis C (CHC) is a medical condition that has broad implications for a person's physical and psychological health.
OBJECTIVE: The aim of this study was to detect changes in liver enzymes and psychological well-being in response to aerobic exercise training in patients with CHC.
MATERIAL AND METHODS: Fifty CHC patients were included in two equal groups. The first group (A) received aerobic exercise training in addition to their regular medical treatment. The second group (B) received no training and only has their regular medical treatment. The program consisted of three sessions per week for three months.
RESULTS: There was a significant decrease in mean values of Alkaline Phosphatase (ALP), Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Gamma - Glutamyltransferase (GGT), Beck Depression Inventory (BDI ) & Profile of Mood States(POMS) and increase in Rosenberg Self-Esteem Scale (RSES) in group (A) after treatments, but the changes in group (B) were not significant. Also, there were significant differences between mean levels of the investigated parameters in group (A) and group (B) at the end of the study.
CONCLUSION: Aerobic exercise training improves hepatic enzymes and psychological well-being in patients with chronic hepatitis C.

Entities:  

Keywords:  aerobic exercise; chronic hepatitis C; liver enzymes; psychological well-being

Mesh:

Substances:

Year:  2014        PMID: 25320592      PMCID: PMC4196401          DOI: 10.4314/ahs.v14i2.18

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  23 in total

Review 1.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

2.  Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C.

Authors:  Robert J Fontana; Steven M Schwartz; Achamyeleh Gebremariam; Anna S F Lok; Cheryl A Moyer
Journal:  Psychosomatics       Date:  2002 Sep-Oct       Impact factor: 2.386

3.  NAFLD: The role of exercise in treating NAFLD.

Authors:  Elena Reynoso; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

4.  Physical activity and health-related quality of life in liver transplant recipients.

Authors:  P Painter; J Krasnoff; S M Paul; N L Ascher
Journal:  Liver Transpl       Date:  2001-03       Impact factor: 5.799

Review 5.  Exercise and the liver: implications for therapy in fatty liver disorders.

Authors:  Nathan A Johnson; Shelley E Keating; Jacob George
Journal:  Semin Liver Dis       Date:  2012-03-13       Impact factor: 6.115

6.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

7.  Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment.

Authors:  G Bianchi; C Loguercio; D Sgarbi; R Abbiati; C H Chen; M Di Pierro; D Disalvo; S Natale; G Marchesini
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

8.  Management of the extrahepatic symptoms of chronic hepatitis C: feasibility of a randomized controlled trial of exercise.

Authors:  Olivia McKenna; Caitriona Cunningham; Conor Gissane; Catherine Blake
Journal:  Am J Phys Med Rehabil       Date:  2013-06       Impact factor: 2.159

9.  Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.

Authors:  Michael R Kraus; Arne Schäfer; Hermann Faller; Herbert Csef; Michael Scheurlen
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Depression and fatigue in chronic hepatitis C patients with and without HIV co-infection.

Authors:  Mohammad Tavakkoli; Stephen J Ferrando; Judith Rabkin; Kristen Marks; Andrew H Talal
Journal:  Psychosomatics       Date:  2013-06-04       Impact factor: 2.386

View more
  2 in total

Review 1.  Natural History of Hepatitis C.

Authors:  Shilpa Lingala; Marc G Ghany
Journal:  Gastroenterol Clin North Am       Date:  2015-08-25       Impact factor: 3.806

2.  Comparison of the Treatment Efficiency of Bone Marrow-Derived Mesenchymal Stem Cell Transplantation via Tail and Portal Veins in CCl4-Induced Mouse Liver Fibrosis.

Authors:  Nhung Hai Truong; Nam Hai Nguyen; Trinh Van Le; Ngoc Bich Vu; Nghia Huynh; Thanh Van Nguyen; Huy Minh Le; Ngoc Kim Phan; Phuc Van Pham
Journal:  Stem Cells Int       Date:  2015-12-29       Impact factor: 5.443

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.